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ABSTRACT. 
The records of all patients on 'whom the cytological diagnosis of endocervical 
glandular atypia had been made by the Department of Anatomical Pathology, 
Cytopathology division, at Groote Schuur Hospital during 1987 were investigated. 
The diagnosis was reviewed in all cases in which there was a complete five year 
follow-up. This included those cases in which the original smears, clinical 
records and patient details were available. A total of 407 (53. 7% of the 
patients who had received the cytological diagnosis of endocervical glandular 
atypia) met these inclusion criteria. 
The terminology applied to these cases was mild, moderate and severe 
endocervical glandular atypia (EGA) and graded for the purposes of this study 
into grades 1, 2, and 3 respectively. If the diagnosis of adenocarcinoma in situ 
(AIS) was suggested these were graded as 4. 
It was found that no consistent diagnostic criteria had been applied in making the 
original diagnoses. Sixty seven percent of the grade 1 and grade 2 atypias 
regressed and the majority of the remainder did not progress. On review of the 
grade 1 cases, the majority showed anisonucleosis and regenerative changes only, 
although some of those which persisted were associated with low grades of 
squamous cervical intraepithelial neoplasia (CIN) and/or human papilloma virus 
infection (HPV) infection. There were similar findings in the grade 2 group, 
except that a higher proportion were associated with squamous CIN of all . grades, 
and the majority of these persisted. 
In the more severe lesions the association with squamous CIN3 was a prominent 
finding and this appeared to be related to a difficulty in differentiating CIN3 
with gland involvment from AIS and pure endocervical glandular atypia. 
Histological correlation in these severe grades showed that only 15% of grade 3 
were related to a glandular neoplastic or preneoplastic lesion and only 54% of 
grade 4 showed correlation with glandular neoplasia. Microglandular hyperplasia 
was misinterpreted as severe EGA/ AIS in 10% of grades 3 and 4. 
In view of these findings, it is recommended that in future endocervical glandular 
abnormalities be classified in terms of causation, if possible, and the diagnosis of 
mild and moderate atypia should not be made i.ndiscriminantly. Where squamous 
abnormalities predominate, the appropriate diagnosis should be given, and the 
diagnosis of EGA or AIS should be reserved for those cases which show 
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1. INTRODUCTION 
Diagnostic cytology of the female genital tract was introduced by Papanicolaou 
(Papanicolaou 1928) in 1928 in New York and almost simultaneously by Babes 
(Babes 1928) in Bucharest. However, neither of these early publications made 
significant impact at that time and it was not until the 1950's when Papanicolaou 
published his atlas (Papanicolaou 1954) that the Pap smear became a meaningful 
diagnostic test. Today four decades after the publication of that atlas and several 
critical assessments of the value of the cytological test, it can be stated that 
the Pap smear must rate as one of the most effective public health tools that 
ha& ever been introduced. 
Reduction of the mortality from squamous carcinoma of the cervix has been 
eloquently demonstrated (Boyes et al 1977, Fiddler et al 1968, Guzick 1978, 
Stenkvist et al 1984) and in the United States according to the American Cancer 
Association statistics, (American Society of Cytology 1988) death rate from 
cervical cancer has decreased by more than 70% in the last 40 years. 
Firm criteria have been established for the cytologic, colposcopic and histologic 
features of the precursor lesions of squamous carcinoma of the uterine cervix 
despite the fact that the terminology applied to these lesions remains under 
dispute. The identification of the precursor lesions of adenocarcinoma of the 
cervix is, comparatively, in its infancy. Initial histopathologic descriptions of 
precursor lesions are commonly based upon observations of cytological 
abnormalities in non-invasive lesions at the periphery of invasive carcinoma. 
Further evidence for the malignant potential of such peripheral lesions must rest 




cases (Buscema & . Woodruff 1984). This, however, has not been unequivocally 
shown. 
1.1 PRECURSOR LESIONS OF ADENOCARCINOMA OF THE CERVIX 
l.l.l.ADENOCARCINOMA IN SITU 
Although alluded to by Hauser in 1894 (Hauser 1894) and Meyer in 1930 (Meyer 
1930), the introduction of the term "AIS" is credited to Freidell and ¥cKay who 
in 1953 described two e~amples (Friedell & McKay 1953). Because AIS is an 
uncommon lesion, pathologists and cytologists may not be familiar with its 
. 
microscopic appearances and it is ~robably under-diagnosed~ V~rious pathologists 
and .cytopathologists have attempted to clarify the situation with the introduction 
of expanded criteria (Quizelbash 1975, Christopherson et al 1979, Bousfield et al 
1980, Boon et al 1981, Wells & Brown 1986, Ayer et al 1987, Betsill & Clark 
1986) .. 
AIS has a varied histology, with three main histological subtypes: (a) endocervical 
type, (b) endometrial type, and (c) intestinal type. Endocervical AIS, either alone 
or in combination with other types was the most frequent variety. Miscellaneous 
types including adenosquamous, and clear cell, are rarely seen (Hasumi & 
Ehrmann 1987). 
1.1.1.1 Endocervical AIS 
This is characterized by nuclear stratification, moderate amounts of juxtaluminal 
cytoplasm (Ill.l), scattered· mitoses and apoptotic bodies. Within Papanicalaou 
(Pap) smears, endocervical AIS is characterized by rosettes with prominent 
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nuclear pseudostratification, strips and crowded sheets of cells (Coleman & Evans 
1988). The nuclei are enlarged, show hyperchromasia and generally show finely to 
moderately granular chromatin. Macronuclei may be encountered and apoptosis 
and ·mitotic activity is universally present. Abnormal mitoses may be identified. 
The architectural features are of primary diagnostic importance and are tabulated 
(Table 1). (Ayer et al 1987). 
TABLE I: 
ARCHITECTURAL FEATURES OF 46 SMEARS WITH AIS 
(Ayer et al 1987) 
Exfoliation features. no. with feature present 
Tightly- crowded sheets 46 
Loosely crowded sheets 0 
Strips off the sheets 38 
Isolated strips 40 
Rosettes 36 
Gland openings 41 
Feathering 35 
1.1.1.2 Endometriod AIS 
This is characterized by marked nuclear pseudo-stratification and absent 
intracytoplasmic vacuoles and with Pap smears thick "chunky" strips of cells are 
seen with exaggerated nuclear pseudo-stratification and scanty cellular cytoplasm. 
(Ill 2) 
1.1.1.3 Intestinal AIS: 
The existence of this type of AIS was alluded to by Qizilbasch (1975) and Gloor 
& Ruzicka (1982) however, it was Trowell (1985), who focussed major attention to 
the presence of argentaffin cells and goblet cells producing sialomucin. With Pap 
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smears, intestinal AIS is characterized by sheets of glandular cells with abundant 
opaque cytoplasm with large secretory vacuoles. The nuclei tend to be larger, 
rounded and more pleomorphic than those usually seen in endocervical AIS. 
(Ill 3 & 5) 
The distribution of AIS in the cervix has important diagnostic and therapeutic 
implications and the usual pattern is that of transformation zone involvement and 
there is frequently overlying metaplastic and dysplastic squamous epithelium. 
Some investigators indicate that AIS is focal or ·localized while others report that 
it is usually extensive (Lauchlan & Penner 1967, Gloor & Ruzicka 1982). 
The question of multifocality has only been addressed in a few reports and is 
thought to occur in approximately 15% of cases (Ostor et al 1984, Bertrand et al 
1987). 
The glands of AIS are usually surrounded by a compact stroma, but in the 
presence of concomitant cervicitis an oedematous stroma with an inflammatory 
infiltrate may be present. Cytologically an inflammatory background is commonly 
encountered occurring in almost two-thirds of cases. A blood stained background 
is present in half and does not necessarily signify invasion (Jaworski et al 1988). 
1.1.2 ENDOCERVICAL GLANDULAR DYSPLASIA 
Endocervical glandular dysplasia (EGO) may be defined as a lesion showing 
cytological and architectural atypia similar to adenocarcinoma in situ (AIS) but of 
lesser degree (Barter & Waters 1970, Bousfield et al 1980). Uniform histological 
criteria have not been widely accepted for EGO, and there is not yet solid 
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evidence of the progression of lesser degrees of EGD or atypias to carcinoma, 
either in situ or invasive. Three proposed classifications have been published in 
the last few years. Each of the classifications divides the. pre-invasive changes 
into three categories: Van Roon et al (1983) use the terms mild/moderate atypia, 
severe atypia, and AIS; similarly, Brown & Wells (1986) and Wells & Brown (1986) 
use the terms low grade cervical glandular atypia (CGA), high grade CGA and 
AIS; and most recently, Gloor & Hurliman 1986, coined the term cervical intra 
epithelial glandular neoplasia (CIGN), divided into three grades. All four papers 
concentrate on the morphologic description of endocervical abnormalities without 
presenting follow up data to document the clinical utility of the classification. 
Van Roon et al (1983) examined glandular epithelium in 208 cervical specimens, 
including 25 cases with mild/moderate atypia, 11 with severe atypia, and 20 with 
AIS. The diagnostic category as based on morphometric analysis of the degree of 
cytological change, ranging from mild to marked nuclear enlargement· with 
variable distortion of the mean nuclear axis. Associated architectural changes 
included adenomatous changes, defined as glandular crowding and 
pseudostratification, and intraluminal shedding of atypical cells. The higher the 
degree of atypia, the more cases with adenomatous changes and intraluminal 
shedding there were. Reserve cell hyperplasia was frequently associated with 
cases classified as mild atypia. The mean patient age was 39.2 years. 
Brown & Wells (1986) studied glandular atypias associated with CIN III lesions 
because of the known association between cervical intra-epithelial neoplasia (CIN) 
and AIS in the cervix. Seventeen cases of cervical glandular abnormalities were 
found: nine cases were considered to have low grade cervical glandular atypia, 
seven high grade cervical glandular atypia, and one AIS. The descriptions stressed 
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architectural as well as cytological abnormalities, low grade atypia having only 
minor deviations of glandular profile with intraluminal tufting anQ papillae and 
high grade atypia having more branching and budding of glands. The cytologic 
features of low grade atypia included nuclear enlargement and hyperchromatism, 
and stratification of nuclei limited to the basal two-thirds of the epithelium. 
High grade atypia was described as having pleomorphic, enlarged nuclei displaying 
hyperchromatism with occasional vesiculation, and stratification greater than two-
thirds of the epithelial height. Less than one mitotic figure was seen per gland in 
high grade atypia. The single case designated AIS showed even more pronounced 
nuclear enlargement and numerous mitoses. Architecturally, glands were generally 
smaller than normal and crowded back to back. Transitional areas of lesser 
atypia were identified in the AIS case. All lesions were multifocal and often 
·located high in the canal. The mean age of the .16 "atypia" patients was 36.9 
years, and there was no consistent correlation with menstrual cycle or 
endometrial abnormalities. Because patients having atypia were slightly younger 
than the patients with AIS in some series and because of finding atypia at the 
border of AIS, the authors concluded that there was evidence of neoplastic 
progression . 
. Gloor & Hurliman (1986) described 23 cases of endocervical glandular lesions, all 
of which had foci equivalent to in situ adenocarcinoma. Foci with lesser 
degrees of atypia were variably present in all the lesions; these foci were divided 
into histological grades using the term CIGN, in analogy to the term CIN applied 
to squamous lesions. The criteria they used are similar to commonly applied 
criteria in the evaluation of gastrointestinal glandular dysplasia. CIGN grade I 
was characterized as having slightly hyper-chromatic nuclei, basally located, 
without significant stratification. CIGN grade II showed some pseudo-
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stratification, crowding of nuclei, and more frequent mitoses. CIGN grade III was 
equivalent to classically described adenocarcinoma in situ, with distinct nuclear 
hyperchromasia, nuclear stratification, loss of basal location of nuclei, and 
decreased mucin. Architectural distortions were not commented upon. Further, 
Gloor & Hurliman (1986) also subdivided the cases into types A and B, type A 
containing the normal mucin pattern and type B resembling intestinal goblet cells. 
The significance of subdividing the lesions into these types is unknown. The 
average age of the reported patients was 34, similar to other series of AIS. 
CIN was a term which evolved through the need to provide more consistent 
pathological diagnoses and to couple the pathologic interpretation with clinical 
management decisions, whereas CIGN was created de novo,· without clinico-
pathologic correlation. At this time, proof that CIGN grade I progresses to 
CIGN grade II or III is absent. In addition, the lack of HPV in glandular atypias, 
which can be demonstrated in adjacent adenocarcinomas, has been taken as 
evidence that the development of adenocarcinoma may not evolve through a 
dysplastic sequence (Farnsworth et al 1989). 
1.1.3 THE BETHESDA SYSTEM 
Terminology is obviously a problem and there is no consensus as to what 
glandular atypias should be called. 
The Bethesda System (Addendum I) attempts to provide uniform diagnostic 
terminology in cytology reporting (Vooijs 1990, Solomon 1992). Atypical 
glandular cells of undetermined clinical significance (AGUS) is the term TBS uses 
to encompass these atypical endocervical glandular lesions and this terminology is 
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commented on by Dianne Solomon in the Compendium of Diagnostic Cytology 
(Solomon 1992). These cells demonstrate changes beyond those encountered in 
benign reactive processes yet that are insufficient for a diagnosis of invasive 
adenocarcinoma. Therefore, lesions in this category include a morphologic 
spectrum from atypical-appearing reactive processes to adenocarcinoma in situ 
(AIS). 
Atypical endocervical cells of undetermined significance may be further 
subclassified according to whether a reactive or a premalignant/malignant process 
(AIS) is favoured. Atypical endocervical cells of undetermined significance, 
probably reactive, demonstrate nuclear enlargement three to five times normal 
and slight hyperchromasia. A honeycombed pattern with distinct cell borders is 
often maintained. Atypical endocervical cells of undetermined significance, 
probably AIS, are characterized by cellular strips and rosettes demonstrating 
elongated, overlapping nuclei with moderately coarse chromatin and 
hyperchromasia. It may be difficult to differentiate SIL with gland involvement 
from AIS. 
1.2 AETIOLOGY OF ENDOCERVICAL ADENOCARCINOMA 
The risk factors for cervical adenocarcinomas seem more comparable to 
endometrial carcinoma than squamous carcinoma (Korhonen 1984). Estrogens, 
either endogenous or exogenously administered, are clearly implicated as etiologic 
factors in some cases of endometrial carcinoma. In parallel with the 
endometrium, the glandular epithelium of the endocervix is hormonally responsive. 
A number of epidemiologic studies have been addressed to the issue of the 
relationship between oral contraceptive (OC) use and cervical carcinoma; however, 
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most of them suffer from confounding factors such as sexual history, detection 
bias, and selection of contraceptive use (Taylor et al 1967, Stern 1977, Vessey et 
al 1983, Celentano et al 1987, Ebeling et al, 1987, Irwin et al 1988). · Of the 
case control studies, the majority favor OC's being etiologically important, with 
relative risks increasing with increasing duration and early onset of use (Schwartz 
& Weiss 1986). Peters et al (1986) examined a population-based tumor registry 
for Los Angeles and found that among women under 35 years of age, there was 
an increase of about 8% per year of cervical adenocarcinoma between 1972 and 
1982. 
In the late 19(;)0's a distinct type of endocervical glandular hyperplasia, designated 
by Kyriakos et al (1968) as "micro-glandular hyperplasia" was recognized as the 
result of oral contraceptive use. This lesion could be mistaken for well-
differentiated adenocarcinoma (Jones & Silverberg 1989). Microglandular 
hyperplasia was seen in only a minority of oral contraceptive users, and a similar 
lesion had been previously described in pregnancy (Nichols & Fidler 1971). There 
has been no evidence that microglandular hyperplasia progresses to endocervical 
carcinoma. 
However, there have been several reports of endocervical adenocarcinomas 
occurring in conjunction with the use of oral contraceptives. The most convincing 
study was by Dallenbach-Hellweg (1984) who reported that of 28 patients having 
invasive adenocarcinoma, 23 had a history of oral contraceptive usage. 
Microglandular hyperplasia was diagnosed prior to or coincident with carcinoma in 
all the women using OC's. No other authors have demonstrated as strong an 
association. 
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From epidemiological studies, a sexually transmitted infectious agent has been 
suspected in the etiology of cervical carcinoma. During the past decade, clinical, 
pathological and molecular studies have all pointed to the human papilloma virus 
(HPV) family of viruses as the most likely group of agents. Earlier studies 
stressed the importance of keratinizing epithelium as the specific target cell of 
HPV; however, more recent studies have documented the presence of HPV in 
glandular epithelium of the endocervix (Tase et al 1988, Okagaki et al 1989, 
Griffin et al 1991). This evidence, together with the high percentage of 
adenocarcinomas with concurrent squamous cervical intra-epithelial ·neoplasia 
(CIN), lend support for a common etiology of both squamous and glandular 
neoplasms. The bulk of the evidence links HPV type 18 to endocervical 
adenocarcinoma- and adenosquamous carcinomas. HPV 16 has also been 
demonstrated in a minority of glandular carcinomas of the endocervix. DNA 
sequences of HPV have been documented in in situ adenocarcinomas of the 
endocervix, but not in "atypias" of the endocervix (Tase et al 1989). A 
disproportionately small percentage of adenocarcinomas in situ contain detectable 
HPV 18 compared to invasive carcinomas, and it has been proposed that HPV 18 
may induce a more rapid malignant transformation than do some of the other 
HPV types (Kurman et al 1988). 
Other infectious agents may act as co-carcinogens, including herpes virus. 
Pertinent studies (Wentz et al 1981, Zur Hausen 1982) are primarily of squamous 
cervical cancers; nevertheless, the conclusions may be applicable to 
adenocarcinomas as well. Numerous retrospective studies show that a higher 
percentage of women with cervical carcinoma have antibodies to herpes virus 
type 2 than do matched controls. However, one large prospective study 
11 
demonstrated no difference in the rate of cervical carcinoma in patients with 
herpes virus type 2 and controls (Vonka et al 1984). 
1.3 PSEUDONEOPLASriC BENIGN GLANDULAR LESIONS OF THE CERVIX 
In Lee et al's 1991 article, benign endocervical conditions are grouped together 
when compared with AIS. All of these benign conditions have lead to problems 
in cytological interpretations and have lead to false positive diagnosis of AIS. 
These benign conditions included tubal metaplasia and focal endometriosis, but the 
majority showed only cervicitis with varying degrees of reactive glandular 
hyperplasia. Other authors (Pacey et al 1988, Novotny et al 1992) have also found 
tubal metaplasia, endometriosis and micoglandular hyperplasia as the only 
histological findings in cone biopsies performed as a result of the cytological· 
diagnosis of AIS. 
Young and Clement 1991, give an overview of pseudoneoplastic glandular lesions 
of the uterine cervix. It is their experience that certain benign glandular lesions 
pose diagnostic difficulties as they may have atypical architectural and/or 
cytological features. These conditions are reviewed in their article and include: 
1. Papillary endocervicitis 
2*. Tunnel clusters 
3*. Deep glands and deep Nabothian follicles 
4. Microglandular hyperplasia 
5*. Mesonephric hyperplasia 
6. Diffuse laminar endocervical glandular hyperplasia 
7. Glandular hyperplasia, not otherwise specified 
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8. Metaplasia (tubal, endometrial, intestinal) 
9. Endometriosis 
10. Arias-Stella reaction 
11 *. Changes secondary to extravasation of mucin 
12. Infective and reactive atypias and other miscellaneous lesions 
Those conditions asterisked (*) occur deep to the superficial lining epithelium of 
the endocervical canal and do not constitute a cytological diagnostic problem. All 
of the other conditions may be problematic both cytologically and histologically. 
1.3.1 PAPILLARY ENDOCERVICITIS 
This is perhaps the most common of the discussed lesions and there is a complex 
micropapillary pattern associated with chronic endocervicitis. If there is in 
addition reactive atypia, this may be interpreted as a neoplastic glandular lesion. 
1.3.2 MICROGLANDULAR HYPERPLASIA (MGH) 
This lesion was often in the past confused with adenocarcinoma until its benign 
nature was appreciated in 1960 (Taylor et al 1967, Kyriakos et al 1968). MGH is 
usually related to progesterone stimulation and occurs typically in young women 
(mean age 33,5 years). 
Microscopically MGH is characterized by closely packed glands that usually 
contain mucin secretion with or without inflammatory cells. The cells lining the 
glands are usually low columnar and there is often subnuclear vacuolation. The 
nuclei are almost always round and regular but rarely may have mild or moderate 
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atypical features. This combination of glandular hyperplasia with on occasion 
nuclear atypia can give rise to problems in cytological interpretation (Young & 
Scully 1989). 
1.3.3 DIFFUSE LAMINAR ENDOCERVICAL GLANDULAR HYPERPLASIA 
This term has recently been ·proposed for a subset of cases of endocervical 
hyperplasia characterized by a diffuse distribution of closely packed endocervical 
glands appearing as a superficial discrete layer. The mean age was 37 with no 
hormonal history of note and all lesions were incidental findings. Reactive 
cytological atypia was seen in some cases, b~t significant atypia was absent. 
Again this combination of hyperplasia with reactive atypia may be problematic in 
cytological interpretation (Jones et al, in press). 
1.3.4 GLANDULAR HYPERPLASIA NOT OTHERWISE SPECIFIED 
It is not widely appreciated that the endocervical epithelium may be hyperplastic, 
sometimes floridly so, without exhibiting any of the specific aforementioned 
patterns. 
1.3.5 METAPLASIAS 
1.3.5.1 Tubal metaplasia 
Tubal metaplasia of the endocervix may be misinterpreted as EGD or AIS 
histologically or cytologically. It is characterized by normal endocervical glands 
lined by ciliated cells, non-ciliated cells and peg cells as seen in the normal 
tubal mucosa. Tubal metaplasia occurs in as many as 31% of cervices (Sub & 
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Silverberg 1990). Its frequency was, as expected, related to the number of 
sections examined. The problem was addressed by Novotny et al (1992) who 
reviewed cervical smears in which a diagnosis of EGD was suggested. 
Retrospective review of the cytology smears and histological slides from these 
patients revealed tubal metaplasia in 66% of cases. Terminal bars and cilia were 
the most helpful· features in the cytological recognition of tubal metaplasia. 
Generally irregular crowded sheets with frayed or feathered edges with rosettes 
which are characteristic of AIS are lacking. Cilia unfortunately are particularly 
susceptible to drying artifacts and pH changes and may be difficult to discern in 
improperly prepared cervical smears. 
1.3.5.2 Endometrial metaplasia 
Pure endometrial metaplasia is rare and is usually a component of · tubal 
metaplasia (Ismail 1991) and the above mentioned features are noteworthy. 
1.3.5.3 Intestinal metaplasia 
The rarest form of benign glandular metaplasia is intestinal in type and is 
~characterized by goblet cells and argentaffin cells. Intestinal metaplasia is seen 
more commonly as a type of AIS and is discussed in that section. 
1.3.6 ENDOMETRIOSIS 
Cervical endometriosis may be superficial (also called primary) or deep (also 
termed secondary) (Clement 1990). Superficial endometriosis which is of relevance 
cytologically, is found in approximately 1% to 2% of the reproductive age group. 
It is usually found in a patient with a prior procedure, such as cone biopsy, 
which has involved the cervix (Ismail 1991). This entity is more problematic 
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cytologically rather than histologically and needs to be considered when 
contemplating the diagnosis of AIS or EGO in a previously conized patient. The 
cells are, however, smaller and more regular than endocervical dysplastic cells, 
and a stromal component may be present. 
In post cone biopsy smears lower segment endometrium may be sampled; 
particularly when an endocervical brush is used. The unwarey may interpret the 
thick sheets of glandular cells as atypical endocervical cells. The nuclei are 
however all completely normal. 
1.3.7 ARIAS-STELLA REACTION 
The Arias-Stella reaction has been documented in endocervical glands in 9% of 
gravid hysterectomy specimens (Schneider 1981). The cytological features are 
similar to those of Arias-Stella within endometrial glands. The pleomorphic hob-
nailed cells may lead to problems in interpretation, but the marked pleomorphism 
in an otherwise normal appearing cervix without a tumour diathesis on Pap-smear, 
should alert the cytologist to the diagnosis, particularly if a clinical history of 
pregnancy is given. 
1.3.8 INFECTIONS AND OTHER REACTIVE ATYPIAS 
Viral endocervicitis, radiation damage and marked inflammation with reactive 
atypia are all pitfalls, and need to be excluded before the cytological diagnosis 
of EGO is given (Michael et al 1984). Atypical reparative cells are notoriously 
difficult to interpret on cytology smears, and careful" attention needs to be 
applied to the morphology (Giersson et al 1977). 
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A last problem area is related to the presence of reserve cell hyperplasia which 
may accompany immature squamous metaplasia. Interpretation of these small, 
somewhat crowded cells may be difficult on a cervical smear and this change has 
variously been diagnosed as AIS, CIN3 (small cell) and exfoliated endometrial 
cells (Michael et al 1984). 
1.4 DIAGNOSIS OF PRECURSOR LESIONS OF ENDOCERVICAL 
ADENOCARCINOMA 
Diagnosis remains problematic particularly as symptomatology is usually absent. 
Cervical cytology may be useful as a screening test but false negative ·rates as 
high as 49% have been reported (Hurt et al 1977). The incidence of false 
positive and negative results first depends on the quality of the material 
submitted, cytobrush specimens yielding more abundant material (Trimbos & 
Arentz 1986, Dotters et al 1988, Weitzman et al 1988), and secondarily the 
diagnostic accuracy of the interpreters. Colposcopy likewise has a high false 
negative rate because of the high endocervical or deep cleft nature of most 
carcinomas (Bertrand et al 1987). Lastly endocervical curettage and cervical 
biopsy occasionally fail to reveal carcinoma when cytology shows malignant cells 
and cone biopsy may be necessary. 
These problems no doubt contribute to the relative increase of adenocarcinoma, 
particularly in first world countries (Tasker & Collins 1974). Several articles 
note that adenocarcinoma and adenosquamous carcinoma now constitute a 
significant proportion of all invasive cancers of the cervix (table II). Other 
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factors are of course contributory including a relative decrease of squamous 
carcinoma as a result of successful screening activity 
TABLE 0: 
PROPORTION OF ADENOCARCINOMA AND ADENOSQUAMOUS 
CARCINOMA IN TOTAL SERIES OF INVASIVE CARCINOMA OF CERVIX 
Authors 
Gallup et al 1985 
Weiss & Lucas 1986 
Tamimi & Figge 1988 
Reagan & Ng 1988 
Horowitz et al 1985 
Berek et al 1985 
Shingleton et al 1981 
Mayer et al 1976 
Julian et al 1977 












There is a prominent association between AIS and squamous CIN (Ill 4). The 
percentage of cases of AIS showing CIN 1-3 varies between 47,8% and 71,4% and 
the AIS: CIN3 ratio varies from 1 : 26 up to 1 : 237 {Jaworski et al 1988). A 
common causative factor has been postulated (Alva & Lauchlin 1975, Maier & 
Norris 1982). 
Most authors in discussing the subject of EGD, EGA, CIGN particularly in the 
cytology literature do not give definite criteria but others emphasize the 
spectrum of changes occurring in glandular epithelium with AIS considered the 
most severe lesion in the spectrum (Brown & Wells 1986, Ayer et al 1987, 
Jaworski 1990). As glandular epithelium can show "atypical" changes which are 
not necessarily "dysplastic" or "pre-neoplastic", this does not allow clarity of the 
problem. 
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Jaworski et al compared histologically the cytological and architectural 
appearance of AIS and EGD (Jaworski RC., 1990). Table III demonstrates these 
differences. 
TABLE ill: 
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A similar comparison of the features of AIS and EGA has not been attempted in 
the cytology literature but Lee et al 1991 compares cytological and architectural 
features between AIS and benign conditions. (Table IV) 
TABLE IV: 






Predominance of N/C ratios > 1/2 
Predominance of groups < 50 cells 
Mitoses . 
Strips with polarity 
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In recent years at Groote Schuur Hospital Cytology Department (GSH) there has 
been an increase in the number of so-called mild endocervical glandular atypias 
(EGA's) (see Table V). They have increased from 0,9% of the total number of 
Pap-smears screened in 1987 to 1,9% of the total in 1991. Whilst the total 
percentage of atypical smears has remained constant (4,4% in 1987 to 4,5% in 
1991) the total number of EGA's within this group has increased from 25,3% in 
1987 to 48,6% in 1991 and the only grade which has shown an increase has been 
the grade 1 or so-called mild endocervical glandular atypias. The other grades 
have remained relatively constant as a percentage of the total smears and total 
atypical smears. 
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The terminology used at GSH for endocerviCal glandular changes which do not 
fulfill the criteria for AIS is endocervical glandular atypia, which is graded as 
mild, moderate and severe. Where cytological features as mentioned earlier, 
- suggest AIS, this diagnosis is given either suspicious of AIS or diagnostic of AIS, 
depending on the degree of certainty. For the purposes of this study these mild, 
moderate and severe endocervical atypias will be called Grade 1, 2, 3 EGA 
respectively and a diagnosis suspicious of AIS will be called Grade 4 EGA. 
TABLE V: 
GROOTE SCHUUR STATISTICS 1987-1991 SHOWING GRADFS OF EGA 
1987 % 1988 % 1989 % 1990 % 1991 % 
·Grade 1 592 78.1 * 1102 79.2* 1335 81.4* 1147 86.4* 1381 85.0* 
(Mild EGA) 0.9+ 1 . 5+ 1 . 6+ 1. 6+ 1 . 9+ 
19.7# 28.0# 28.9# 27.4# 41 .3# 
Grade 2 126 17.2* 223 16.0* 248 15. 1 * 164 12.4* 215 13.2* 
(Mod. EGA) 0.2+ 0.3+ 0.3+ 0.2+ 0.2+ 
4.3# 5.7# 5.4# 3.9# 6.4# 
Grade 3 24 2.6* 47 3.4* 45 2.7* 12 0.9* 25 1. 5* 
(Severe EGA) 0.0+ 0. 1+ 0. 1+ 0.0+ 0.0+ 
0.7# 1. 2# 1. 0# 0.3# 0.7# 
Grade 4 1 1 1 . 5* 12 0.9* 2 0.1 * 1 0.1 * 1 0.1 * 
(AIS) 0.0+ 0.0+ 0.0+ 0.0+ 0.0+ 
0.4# 0.3# 0.0# 0.0# 0.0# 
ADENOCA 5 0.7* 7 0.5* 1 1 0.7* 3 0.2* 3 ' 0. 2* 
0.0+ 0.0+ 0.0+ 0.0+ 0.0+ 
0.2# 0.2# 0.2# 0.1 # 0. 1 # 
T.ENDO 758 1 . l+ 1391 1 . 9+ 1641 2.0+ 1327 1 . 8+ 1625 2.2+ 
ATYPIA 25.3# 35.4# 35.5# 31 . 7# 48.6# 
T.ATYP 2998 4.4+ 3934 5.3+ 4622 5.5+ 4191 5.7+ 3342 4.5+ 
TOTAL 67506 74364 83606 73811 74007 
' Legend: 
* % of total EGA, 
+ % of total smears, 
# % of total atypical smears. 
21 
The 100% increase in the proportion of grade 1 EGA in this five year period is 
of great interest because, it occurred in the absence of any similar increase in 
the higher grades. This has important workload implications as well as 
important implications for the patient. The aim of the study was therefore to 
analyse and appraise the grading system used by the Cytology Department of 
Groote Schuur Hospital in categorising endocervical atypical changes and to 
determine, if possible any factors which may be related to the development of 
these changes. 
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2 • METHODOLOGY 
All patient's with recorded atypical endocervical cells on Pap smears processed 
by the Cytology Laboratory at Groote Schuur Hospital in 1987 were investigated. , 
2.1 SELECTION CRITERIA 
+ Computerised patient records based on the SNOMED coding system were 
available. All cases designated mild, moderate, severe endocervical atypia 
and AIS were extracted using this system. 
+ Patient's initial and subsequent Pap smear request and report forms were 
manually drawn from the Record Files. 
These records included 
The original cytological examination request form (appendix 1) 
containing details of the patients age, LMP, exogenous hormonal 
treatment, contraceptive method, macroscopic appearance of the 
cervix including presence or absence of an ectropion. 
The original cytological report for the above. 
Follow-up details with copies of all subsequent request and report 
forms. 
In those cases where all the above details were available the 
original Pap smear was drawn from the slide file. 
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2.2 COLLECTION OF DATA 
2.2.1 CLINICAL DATA 
Clinical data was obtained retrospectively from the original cytology 
request forms. The following information was extracted: 
the patient's name, age, last menstrual period, whether pregnant, whether 
the patient was post-menopausal, whether ' an erosion was present, 
contraceptive use, exogenous hormone use. This data was recorded on a 
specifically designed data collection form. (appendix 2). 
2.2.2 CYTOLOGICAL DATA 
The initial grade of endocervical atypia as assessed by the GSH screening 
cytologist was obtained from the patient's original cytology report and 
recorded on the Clinical and Follow-up Data Collection Form. 
Original smears were rescreened without consulting the records and the 
following characteristics were assessed (see appendix 3): 
2.2.2.1 Architectural features of endocervical cells: 
1.1. Quantity as determined by the number of groups of cells per slide. 
1.2. Presence of extreme crowding, as determined by the degree of nuclear 
overlapping within groups. 
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1.3. The approximate number of cells per group, recording those where the 
majority of groups contained > 50 cells (Ill 6). 
1.4. The presence of feathering of nuclei along the edge of the groups (Ill 6, 7, 
t'o). 
1.5. The presence of loss of polarity in strips.(Ill 11) 
1.6. The presence of rosettes (Ill 12, 13). 
2.2.2.2 Cytological and nuclear features of endocervical cells (Ill 14 - 21). 
2.1 Anisonucleosis as determined by variation· in nuclear size and shape. 
2.2 Nuclear\cytoplasmic ratio greater than 0.5. 
2.3 Thicknel?s of nuclear membrane, recording those cases where a thickened 
nuclear membrane was present in most of the atypical cells. 
2.4 Appearance of chromatin, recording if the chromatin was even, dense, or 
coarse. 
2.5 Appearance of cytoplasm, recording the presence of foamy, vacuolated or 
homogeneous cytoplasm. 
2.6 Presence and· appearance of nucleoli, recording if in the majority of 
endocervical cells nucleoli were absent, micro or macro.(Illustrations .. ) 
2. 7 Absence or presence of mitoses. 
2.8 Absence or presence of apoptosis. 
·2.2.2.3, Background features 
3.1 The presence of blood covering the smear. 
3.2 The presence of inflammatory exudate. 
3.3 The presence of pathogens, indicating if candida, trichomonas, gardnerella, 
herpes, or chlamydia were seen (Ill 22 - 25). 
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2.2.2.4 Features of squamous cells (Ill 26 - 31). 
4.1 Indicating if the squamous cells were atypical. 
4.2 If atypical if there were changes to suggest CINl, -CIN2, CIN3, HPV or 
squamous carcinoma. 
4.3 If there were atypical regenerative or inflammatory changes present. 
If there were any other features of note, these were recorded separately. The 
presence of exfoliated endometrial cells was included under this category of 
miscellaneous abnormalities (Ill 32, 33). 
This data was recorded on a specifically developed data collection form 
(appendix 3). 
2.2.3 FOLLOW-UP DATA 
Manual Cytology Department record files containing patient's initial and 
subsequent Pap smears request and report forms were perused. The 
outcome of the EGA's at the end of the five year follow-up period was 
assessed in terms of the following criteria: 
1. Lost to follow-up. 
2. Regressed on subsequent smears. 
3. Persisted as the same grade of atypia. 
4. Deteriorated to a higher grade. 
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An atypia was regarded as having: 
Regressed when subsequent pap smears during the five year follow up 
period revert to normal without further ·deterioration to significant atypia .. 
Persisted when on subsequent pap smears, during the five year follow-up 
period, the same grade of EGA was recorded without evidence of either 
regression to normal or deterioration to a higher grade of EGA. 
Deteriorated when on subsequent pap smears during the five year follow-up 
period a higher grade of EGA was recorded. Assessment of deterioration 
in the case of grade 3 EGA necessitated subsequent recording during the 
follow up period of grade 4 EGA(AIS). In the case of grade 4 EGA 
deterioration implies subsequent recording of ari invasive lesion 
cytologically. The majority however, of these grade 3 and 4 EGA's where 
not followed up cytologically but where investigated colposcopically and 
histologically. This investigation did not mean the patient was lost to 
follow up and these patients where entered in the" persisted" group. 
This data was recorded on the Clinical and Follow-up Data Collection Form. 
2.2.4 COLLECTION OF HISTOLOGICAL DATA 
If a cervical biopsy, fractional curettage, cone-biopsy or hysterectomy had 
been performed on the patient during the five year follow-up period, the 
histological diagnosis given on these specimens was recorded on the 
Clinical and Follow-up Data Collection Form. 
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2.3 COLLATION AND ANALYSIS OF DATA. 
A specially designed computer programme was written in DBase4 to collate and 
analyse the data captured. The Epistat computer package was used to perform 
statistical testing as required. 
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3. RESULTS 
3.1 SAMPLE AND GRADING. 
There were 758 patients with atypical endocervical glandular cells present on 
their pap smears during 1987. Five of these cases were invasive adenocarcinomas, 
and were excluded for this reason from the study. Of the remaining 753 patients, 
407 (53,7%) patients met the selection criteria. Table VI shows the reasons why 
the remaining patients (346) could not be included in the study sample. 
TABLE VI: 
REASONS WHY PATIENTS WERE NOT INCLUDED IN STUDY SAMPLE 
Reason for exclusion number 
Original request form lost 174 
Original request form incomplete 138 
Original slides lost 34 
Total not meeting inclusion criteria 346 
Table VII shows the grading of endocervical atypias given to patients' Pap smears 
by the GSH cytologists in the total and sample populations. 
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TABLE VII: 
GRADING OF PAP SMEARS IN TOTAL AND SAMPLE POPULATIONS 
Grade Total pop. Study pop. Excluded pop. 
Number % Number % Number % 
1 592 78.1 304 74.7 288 83.2 
2 126 17.2 68 16.7 58 16.8 
3 24 2.6 24 5.9 0 0 
4 1 1 1.9 1 1 2.7 0 0 
Total 753 100 407 100 346 100 
Table VIII shows the age range and grading of patients who met the admission 
criteria. 
TABLE VIII: 
NUMBER OF PATIENTS BY GRADE OF ENDOCERVICAL ATYPIA AND AGE. 
Age range 
(Years): <20 20-29.30-39 40-49 50-59 60+ Total % of 
.' 
Total 
Grade: Patient numbers: 
1 46 117 86 27 18- 10 304 74.7% 
2 3 35 20 3 6 1 68 16.7% 
3 1 10 9 2 1 1 24 5.9% 
4 0 3 4 1 2 1 11 2.7% 
Total so 165 119 33 27 13 407 100% 
% of 
total: 12.2% 40.5% 29.2% 8.1% 6.6% 3.2% 100% 
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3.2 FIVE YEAR FOLLOW-UP OF ~ATIENTS 
One hundred and twenty four patients (30.5%) did not return· for follow up during 
the five year period from 1987 and were deemed lost to follow up. Table IX 
shows the percentage in each grade which were lost to follow up. 
The remaining 283 (69.5%) who were followed up were evaluated according to the 
outcome criteria shown in Table X and Figure 1. 
TABLE IX: 
FOLLOW-UP OF SMEARS. 
Total Lost to Followed 
smears fol.-up up 
Grade 1 
Number 304 108 196 
% 35.5 64.5 
Grade 2 
Number 68 13 55 
% 19. 1 80.9 
Grade 3 
Number 24 3 21 
% 12.5 87.5 
Grade 4 
Number 1 1 0 1 1 
% 0 100 
Total 407 124 283 
% of 
Total 30.5 69.5 
TABLE X: 
OUTCOME MEASURED IN TERMS OF PERSISTENCE, 
REGRESSION AND DETERIORATION 
Followed Persist Regress Deter. 
up 
Grade 1 
Number 196 " 51 - 145 0 % 26.0 74.0 0 
Grade 2 
Number 55 31 22 2 
% 56.4 40.0 3.6 
Grade 3 
Number 21 14 3 4 
% 66.7 14.3 19.0 
Grade 4 
Number ,o 11 10 0 1 
--
% ··- 90.9 0 9. 1 
Total 283 106 170 7 
% of 
Total 37.5 60.1 2.5 
3.2.1 FACTORS INFLUENCING OUTCOME 
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Some of the factors which may have influenced outcome were assessed, including 
associated atypical features of squamous cells (Fig. 2 and Tables XI & XII). 
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TABLE XI: 
ASSOCIATED ATYPICAL FEATURES OF SQUAMOUS CELLS RELATED TO 
PERSISfENT ENDOCERVICAL GLANDULAR ATYPIA 





persisting CIN1 CIN2 CIN3 HPV REGEN squam 
in grade les. 
51 15.7% 2.0% 0.0% 39.2% 19.6% 39 
31 3.2% 32.3% 35.5% 16. 1% 6.5% 29 
14 0.0% 7.1% 71.4% 0.0% 7.1% 12 
10 0.0% 0.0% 3.0% 0.0% 0.0% 3 
TABLE ·XII: 
ASSOCIATED ATYPICAL FEATURES OF SQUAMOUS CELLS RELATED TO 
REGRESSING ENDOCERVICAL GLANDULAR ATYPIA 
Grade Total % of persisting lesions in category Total 
regressing CIN1 CIN2 CIN3 HPV REGEN squam 
in grade les. 
1 145 0.0% 0.0% 0.0% 8.9% 26.9% 52 
2 22 9.0% 0.0% 0.0% 13.6% 27.0% 11 
3 3 0.0% 0.0% 0.0% 0.0% 66.7% 2 
4 0 0.0% 0.0% 0.0% 0.0% 0.0% 0 
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3.3 lDSTOLOGICAL CORRELATION 
The percentage in each grade in which histological correlation was available is 
'. 
recorded in Table XIII. 
The histological diagnosis given in each of these cases is recorded in Table XIV. 
TABLE XIII: 
HISTOLOGICAL CORRELATION OF EGA'S 
Grade Number of patients % of total within 
with follow-up grade. 
cervical histology 
1 8 3% 
2 23 34% 
3 20 83% 
4 1 1 100% 
Total 62 15.5% (of total 
sample of 407) 
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TABLE XIV: 
IDSfOLOGICAL CORRELATION OF ALL GRADES OF EGA 
Histological diagnosis Grade 1 Grade 2 Grade 3 Grade 4 
No. % No. % No. % No. % 
With or without HPV: 
CIN 1 0 0 0 0 
CIN 2 0 5 22% 1 5% 0 
CIN 3 0 10 44% 10 50% 2 18% 
HPV without CIN 5 63% 5 23% 1 5% 0 
Squamous Carcinoma 0 1 4% 1 5% 0 
AIS 0 0 1 5% 4 36% 
Adenocarcinoma 0 0 1 5% 2 18% 
EGO 0 1 4% 1 5% . 0 
MGH 0 1 4% 0 3 27% 
Endocervical polyp 1 13% 0 1 5% 0 
Cervicitis 0 0 1 5% 0 
No abnormality 2,-_· 25% 0 2 10% 0 
TOTAL 8 100% 23 100% 20 100% 1 1 100% 
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3.4 THE CYTOLOGICAL RESULTS 
The cytological aspects of the data collection form were analysed and Figures 2 
to 10 demonstrate these results as well as Tables XV and XVI. 
TABLE XV: 
MITOSES AND APOPTOSIS 
Grade Mitosis apoptosis 
No. % No. % 
. .-
1 - 0 0 0 0 
2 0 0 0 0 
3 3 12.5% 1 4.2% 
4 4 36.4% 3 27.3% 
TABLE XVI: 
INTERPRETATION OF ENDOMETRIAL CELLS ON CERVICAL SMEARS 
Grade Endometrial cells Interpreted as ECA 
no. no. % 
1 18 10 55.5 
2 2 2 100 
3 0 0 0 
4 0 0 0 
'-0 
C""') Figure 1: Five year follow-up . . 
of patients with EGA's~ 
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Fig. 5: Architectural features of 
endocervical groups 
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Ill 2: . 
Endocervical 
stratification 









Endometroid AIS characterized by marked nuclear 
stratification and lack of juxtaluminal cytoplasm 
histologically (H & E, x 200) 
Ill 3: 
Ill 4: 
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' 
Intestinal AIS showing abundant goblet cell 
metaplasia with nuclear stratification. A normal 
endocervical gland is present at the left corner 
(H & E, X 400) 
The presence 
at the right 
of concommitant CIN3 
corner (H & E, x400) 




Goblet cells can be seen · in this c .rowded sheet of 
glandular cells depicting intestinal AIS. (Pap x800) 
Numerous, crowded hypercellular groups of 
endocervical cells with peripheral feathering 
typical of AIS cytologically (Pap x 200) 
Ill 7: 
Ill 8: 
Extreme crowding of 
associated feathering 
confirmed (Pap, x 800) 
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endocervical nuclei and 
the diagnosis of AIS was 
Moderate nuclear crowding without feathering - the 
diagnosis of cervicitis was made histologically 




Although nuclear crowding and hyperplasia is present, 
there is no true feathering the histological 
diagnosis of microglandular hyperplasia was made in 
this case (Pap, x 800) 
A hypercellular group with crowding, loss of polarity 
at the periphery with feathering, in a histologically 
confirmed example of AIS (Pap, x 200) 
Ill 11 : Loss of polarity in short strips of endocervical 
cells is another important architectural feature. 





Rosette formation may either be seen in small groups 
of cells with stratified nuclei or as below (Ill 13) 
within larger groups of crowded nuclei 
(both Pap, x 800) 
• 
Ill 14: 




Small groups of cells with some anisonucleosis and 
prominence of nucleoli are typical of reactive 
endocervical cells (Pap, x 800). (The columnar cell, 
as indicated, has a foamy cytoplasm) 
By comparison as well as anisonucleosis and 
occasional nucleoli, there is chromatin coarseness 
and nuclear crowding in this example of 
adenocarcinoma (Pap, X 800) (Differentiation from 




Chromatin tends to be dense but not coarse in in situ 
adenocarcinoma (Pap, x 800) 
Mitoses are occasionally seen in groups of 




Mitoses can be more frequently, but not invariably, 
seen in cases of in situ adenocarcinoma (Pap, x 800) 
Apoptosis is also a feature of in situ adenocarcinoma 




Vacuolated mucin filled endocervical cells are not 
infrequently seen, sometimes associated with 
microglandular hyperplasia, as in this case 
(Pap, X 800) 
More homogeneous cytoplasm and nuclei with 
macronucleoli. This case was diagnosed histologically 
as invasive adenocarcinoma. Coarse chromatin, 
anisonucleosis and nuclear crowding is also seen 
(Pap, X 800) 
Ill 22: 
Ill 23: 
Pathogens included Candida as seen above 
(Pap, X 800) 
and 
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Gardnerella with clue cell formation as seen below 




Multinucleation, cowdry inclusions and margination of 
chromatin, typical of herpes virocytes were seen in 
the one example (Pap, x 800) 
An inflammatory smear with vacuolation of metaplastic 
cells is a feature of chlamydia (Pap, x 800) 
Ill 26: 
Ill 27: 
Anisonucleosis,coarse chromatin and syncytial 
groupings are features of CIN3 (Pap, x 800) 
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Dysplastic immature metaplastic cells may acquire a 
somewhat honeycomb grouping reminiscent of AIS. Note 
lack of extreme crowding and feathering 




Dysplastic nuclei exhibited marked anisonucleosis, 
with coarse chromatin which lack nucleoli 
(Pap, X 800) 
c 
Reactive endocervical cells with some anisonucleosis, 
even chromatin and micronucleoli (Pap, x 800) 
Ill 30: 
Ill 31: 
Koilocytosis and binucleation associated with HPV 
infection (Pap, x 800) 
Dyskeratotic cells are also a feature of HPV 





Exfoliated endometrial cells tend to cluster as a 3 
dimensional group and the apparent hyperchromasia is 
due to nuclear degeneration (Pap, x 800) 
A flat sheet of endometrial cells with background 
stroma from lower segment endometrium (Pap, x 200) 
Ill 34: Vacuolated 
inflammatory 




· cells in an 
to IUCD usage 
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5. DISCUSSION OF RESULTS 
5.1 SAMPLE 
Three hundred and forty six patients (46.3%) did not meet the selection criteria 
due to inadequate filing of original records. Although computer generated 
reports were available in many instances, these did not contain adequate clinical 
and patient related information and could not be used for the purposes of this 
study. Table VII shows that the sample population and the total population are 
similar, in terms of proportion of patients within each grade of EGA except that 
none of the grade 3 or 4 EGA's. were excluded from the sample. The small 
numbers within these groups did not significantly alter the percentages within the 
other groups. 
The age of the patients in the study population ranged from 14 years to 72 
years, the majority (79.7%) occurring in the 20 to 39 year age group (Table VIII). · · 
Ninety one percent of patients were categorised into grades 1 and 2. As noted in 
Table V, these patients represent an important component of the work load of 
the GSH cytology laboratory. 
5.2 F1VE YEAR FOLLOW-UP OF FATIENTS WITH EGA's 
· 5.2.1 LOST TO FOLLOW-UP 
Thirty point five percent ( 124) of the patients in the sample group did not 
present for follow-up pap smears (Table XI). Of the 124 patients lost to follow-
up. 121 (97.6%) were in groups 1 and 2. Many of those patients lost to follow-
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up (53.7% ) were pregnant patients whose screening pap smear was performed at 
an antenatal clinic. 
5.2.2 FIVE YEAR FOLLOW-UP 
Two hundred and eighty three (69.5%) of patients had been followed-up during the 
five year period from 1987 to 1991. The outcome of these patients with EGA's 
was assessed according to whether their EGA's regressed on subsequent smears, 
persisted as the same grade of atypia or deteriorated to a higher grade. 
5.2.2.1 Grade 1 EGA's 
Figure 1 and Table X show that 145 (74%) of patients with grade 1 EGA's 
regressed. The remaining 51 (26%) EGA's persisted. Table XI shows that 39 
(76.5%) of these persisting lesions were associated with atypical squamous 
epithelial cells. The remaining 12 patients with persisting grade 1 EGA's were 
not associated with any specific features of note. Follow-up smears from these 
patients were rescreened and although anisonucleosis and regenerative changes 
were noted there was no other significant abnormality. 
5.2.2.2 Grade 2 EGA's 
Of the 55 (80.9%) of the grade 2 EGA's which were followed up, 96.4% · either 
regressed or persisted. Of the 56.4% which persisted, 93.5% were associated 
with squamous lesions (Table XI). Two patients atypias deteriorated. These 
were found to be associated with squamous CIN3 extending into crypts on 
subsequent follow up pap smears and on cervical biopsy and one of these 
patient's had an area of microinvasive carcinoma. Review of the original 
smears in both cases showed scanty evidence of CIN3 with atypical immature 
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metaplastic cells possibly having been misinterpreted as EGA by the original 
screening cytologist. The distinction cytologically of primary EGA from squamous 
CIN extending into crypts can on occasions be difficult (Staymates 1982, Lee et 
al 1991) and many of the cases of persistent and deteriorating EGA's appear on 
rescreening to have been misinterpreted in this way . 
5.2.2.3 Grade 3 EGA's 
Twenty one (87.5%) of these patients were followed-up. Here the majority 
(85, 7%) either deteriorated or persisted. Of the 66.7% of atypias which 
persisted, 85.7% were associated with atypical squamous cells. The majority 
(71.4%) where associated with squamous CIN3 . Histological correlation in these 
cases (Table XIV ) confirms CIN3 extending into crypts, in none of these 10 
cases was EGA or AIS noted histologically. However, in 2 of the 4 cases 
which deteriorated, atypical squamous cells were not seen cytologically, but 
histological investigation demonstrated AIS and invasive adenocarcinoma 
respectively. Further, discussion will follow as to the important differentiating 
cytological features .. Of the remaining 2 cases which deteriorated one was found 
to be a squamous carcinoma histologically and the hysterectomy specimen of the 
other surprisingly showed HPV but neither CIN or EGA. 
5.2.2.4 Grade 4 EGA's 
As expected in· this severe grade, the EGA's either persisted or deteriorated. 
Those recorded as "persisted" had histological correlation as well as cytological 
follow up in all cases. Only 3 of these cases (26.3%) were associated with 
atypical squamous cells cytologically, and these atypical changes were assessed as 
CIN3 both cytologically and histologic~lly. In only one of these cases was 
concomitant AIS found histologically. The remainder showed architectural and 
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cytological features suggestive of a pure AIS. The results of histological 
examination in these 11 cases where AIS was suspected cytologically is presented 
in Table XIV. AIS was confirmed in 4 cases (36,3%). In a further 2 cases 
(18,1%) invasive adenocarcinoma was found. In the remaining 3 cases (26,3%) 
microglandular hyperplasia was the only endocervical abnormality found at 
hysterectomy. This is a known pitfall in the cytological diagnosis of AIS 
(Nichols & Fidler 1971, Lee et al 1991,) and the cytological features which may 
be useful· in differentiating these lesions are discussed below. 
The association between grade 1, grade 2 and grade 3 EGA's and abnormal 
squamous cells found in this study is important, because it may have important 
implications for the modification of the system of cytological diagnosis of EGA's 
used by GSH Cytology Department. The distinction between atypical immature 
metaplastic cells involved in CIN or tissue repair and atypical columnar glandular 
cells may be difficult and misinterpretation may occur. In these cases, 
attention should be given to the detail of the architectural groupings and to the 
shapes of the cells. In pure glandular atypia the groupings should retain a 
honeycomb configuration (Ill 6, 7) Focusing into crowded groups of 
hyperchromatic nuclei is necessary to visualise this configuration. The cells 
within these groups, and strips of cells should be columnar, rather than cuboidal 
and mucin production may be visible (Staymates 1982, Coleman & Evans 1988) 
Where the squamous lesion is the predominant abnormality, the smear should be 
classified as a squamous lesion and managed as such with follow-up or treatment 
according to the· grade of squamous abnormality. Squamous and glandular lesions 
can however on occasions occur simultaneously (Brown & Wells 1986),. and the 
presence of CIN3 does not exclude coexistant AIS. The fact that the majority 
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(74%) of the grade 1 EGA's regressed, as did 40% of grade 2 EGA's (FIG. 1), 
implies that these lesions, when not associated with squamous c CIN or HPV 
infection, are related to benign reactive rather than preneoplastic processes (see 
Table XII). 
5.2.2.5 Other factors possibly associated with the occurrence of EGA's 
The study was also designed to test the possible relationship of exogenous 
contraceptive hormones, intrauterine contraceptive device use and the presence of 
ectropions with the occurrence of EGA's, but as Fig. 3 shows, these factors 
occurred randomly and were not associated with the grade of EGA. 
Ectropions were found to be present in between 8% and 22% of each grade of 
EGA. These lesions are not known to cause cervical pathology and are 
essentially physiological changes. There are however cytological features which 
can be ascribed to ectropions. These are: 
an increased number of endocervical cells present on the pap smears 
associated with ectropions (frequently more than 50 cells per group) and a 
propensity to bleeding during exfoliation. 
If in addition to these above features, there are benign reactive changes with 
anisonucleosis, a cytological diagnosis of EGA may mistakenly be made. A 
diagnosis of EGA should only be made if in addition to the above findings, other 
abnormal architectural features are present (see section on cytological features). 
Medroxyprogesterone . (depoprovera) as a form of contraception was used in 89 
patients in the sample. Depoprovera has been implicated with a number of 
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cervical abnormalities , the most important, related to the endocervix, being 
. microglandular hyperplasia (MGH). MGH is characterised by glandular 
hyperplasia and thus increased numbers of cells, as well as cellular crowding 
cytologically (Ill 9). Nuclear abnormalities are usually minimal, but if present can 
lead to confusion with AIS and EGA (Lee 1988, Young & Clement 1991). Three 
cases of grade 4 EGA diagnosed cytologically were found on histological 
assesment to be MGH. This emphasises the importance of MGH as a 
pseudoneoplastic glandular lesion and thus a diagnosis which must be considered in 
all patients receiving progesterone stimulation. Although it has been postulated 
that there is a hormonal factor related to the etiology of endocervical carcinoma 
(Dallenbach-Hellwig 1984), this has not been adequately demonstrated. MGH is 
also found in a minority of oral contraceptive users. In this· study the number 
of people using oral contraceptives was small and no significant relationship 
between grade of EGA and O.C. use was found. 
IUCDs were used by only 14 of the sample group. With this small number of 
cases no relationship could ·be demonstrated between the grading of EGA's 
IUCD's. Usage of the IUCD however, is related to endocervical glandular 
changes as a result of chronic irritation by the IUCD thread (Gupta et al 1978, 
Risse et al 1981). It is important to properly recognise these morphological 
ehanges since they may be confused with glandular neoplastic lesions (Ill 34). 
The presence of HPV on the original pap smear was assessed by koilocytosis and 
dyskeratosis (Ill 30, 31). HPV types 16 and 18 have been demonstrated in a 
number of cases of endocervical adeno carcinomas (Cooper et al 1992). 
Figure 2 shows the features of the associated squamous cells in each grade of 
EGA. There was no significant difference between the frequency of occurrence 
-· 
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of HPV in association with grade 1 and grade 2 EGA's. (p > 0.05). However, 
the morphological features of HPV were not found to be associated with grade 3 
or 4 EGA's. 
c It has been found that HPV DNA is present in 3 morphologically distinct forms in 
the nuclei of CIN and squamous carcinoma by in situ hybridisation techniques 
(Cooper et al 1991). The integration of virus type 16 and 18 may be of 
· importance in carcinogenesis and the morphologically distinctive features may be 
lost. Whereas with non-integrated episomal virus, the morphological features of 
koilocytosis and dyskeratosis are preserved (Cooper et al 1991). The findings in 
this study do not disagree with this theory . 
Organisms, such as herpes virus type 2 (Ill 24), as suggested by the Zur Hausen 
hypothesis (Zur Hausen 1982), may act as co-carcinogens. However, in this study 
only one case of herpes virus infection was found and possible association 
between herpes virus infection and EGA's could not be investigated. 
A number of other organisms were also found in the cervical smears (Figure 4). 
Trichomonas was found to be the most frequently occurring organism, followed by 
Gardnerella and Candida. No consistent association with either grade 1, ·2 or 3 
and type of infection was found. No organisms were found in any of the grade 4 
cases. The reason for this is unclear, but may be related to the small number 
( 11) of cases in the group and thus no significance should be placed on this 
finding. 
(Ill 22-25 demonstrate the cytological features of some of these organisms). 
----~·· -----· 
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Both squamous and endocervical cells contained in these inflammatory pap smears 
showed a high proportion of regenerative changes (Fig.2). Such regenerative 
changes, which are associated with the above infections, in particular 
trichomoniasis (Gupta 1991) tend to regress on follow-up as shown in Table XII) 
and should not be diagnosed as atypical. 
5.3 CYTOLOGICAL FEATURES OF ORIGINAL PAP SMEARS 
There have been only a few comprehensive descriptions of the cytological aspects 
of adenocarcinoma in situ and related lesions (Lee et al 1991, Ayer et al 1987, 
Ayer et al 1988, Krumins et al 1977, Bousfield et al 1980). Endocervical 
glandular dysplasia is a lesion described as showing cytological and architectural 
atypia similar to adenocarcinoma in situ (AIS) but of lesser degree (Barter & 
Waters 1970, Jaworski 1990). 
The word atypia means not normal, or not typical for a normal cell of this 
particular tissue. Vooijis 1991, suggests that the use of the word atypia without 
further specification should be avoided since it can be used too often as a 
substitute for a careful description and definition. Commonly the word atypia is 
used as a descriptive diagnosis when indicating minimal to slight aberrations from 
the normal. Features most frequently causing such a diagnosis of slight to 
minimal atypia are nuclear enlargement and aberrations from the normal 
configuration of the cell. The most often causative processes of this abnormality 
are inflammation and regenerative reactions. Bearing these definitions in mind, 
and considering the features discussed in the introductory chapter the cytological 
findings of each smear with EGA rescreened are presented below. 
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The results of the analysis of those features present within each grade of EGA, 
are grouped into architectural, cytological and background features. Related 
features such as pathogens and squamous cell abnormalities have already been 
mentioned in the preceding discussion, but where relevant will be discussed. 
5.3.1 ARCHITECTURAL FEATURES 
The architectural features chosen for analysis were those assessed to be of 
diagnostic significance by Lee et al 1991 (see Table IV) in differentiating AIS 
from benign conditions. Figure 5 shows that Grade 1 EGA's did not show 
feathering, loss of polarity in strips or rosette forms. Five cases (1 ,6%)) showed 
some nuclear crowding, but the only architectural abnormality which occured with 
any frequency (25,7%) was the presence of >50 cells per endocervical glandular 
group. Those cases which showed nuclear crowding were all cytobrush smears. 
Interpretation of cytobrush smears can at times be difficult because of the 
smearing artifact which can distort the morphology, particularly if forceful 
smearing has occured. Other authors (Novotney et al 1992) have also noted this 
difficulty in interpreting cytobrush smears. 
Grade 2 EGA's did show some nuclear crowding (29,4%)) and 25% had > 50 cells 
per group. Again the other 3 features were not demonstrable. Some of the( cases 
which showed nuclear crowding were again cytobrush smears. 
The original article on the subject of the cytological diagnosis of AIS by Krumins 
et al {1977) and subsequent articles on the subject (Ayer et al 1987, Lee et al 
1991) emphasise the architectural features and in particular extreme nuclear 
crowding, feathering, rosette formation and loss of polarity in strips as being the 
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most important diagnostic features of AIS. A later article by Bousfield et al 
1980, again emphasised these same features and on the subject of endocervical 
glandular dysplasia remarked that in their 3 cases crowded sheets, columnar strips 
and rosettes were also seen. 
As abnormal architectural features were found in the more severe grades of EGA 
it can be assumed that these were the dominant features noticed by the 
screening cytotechnologist. Subsequent histological examinations carried out in 
these cases do not correlate well with the original cytological diagnoses. Table 
XIV shows that only 54,6% of the cases suspected of being AIS (Grade 4 EGA's) 
were in fact adenocarcinomas, either invasive or in situ. In those cases where 
there was a positive correlation, at least 4 of the 5 architectural features were 
present. This was not the case where there was no positive correlation between 
histology and cytology. 
Figure 6, emphasises the above finding. Accumulative architectural features are 
of· more significance in the diagnosis of AIS than any other criterion. 
5.3.2 CYTOLOGICAL FEATURES 
Figure 7, demonstrates that the occurrence of anisonucleosis on its own is not a 
useful feature in the cytological diagnosis of AIS and EGD because, in 95% of 
cases of Grade 1 EGA, it was the only abnormal finding and 75% of grade 1 
cases regressed. 
By comparison the higher grade EGA's showed, in addition to anisonucleosis, a 
predominance of abnormal cells with an NC ratio > 1/2, and an increased number 
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cases with a thickened nuclear membrane. Many of these cases had related 
squamous CIN lesions and these abnormalities are possibly related to involvement 
of endocervical crypts by squamous metaplasia and intraepithelial neoplasia. 
Consequently, the diagnosis should rather have been CIN with endocervical crypt 
involvement instead of EGA. 
Figure 8, demonstrates the chromatin features of the various grades. The Grade 1 
EGA's had even chromatin distribution in 83% of cases. Although the nuclei 
appeared dense and hyperchromatic in 15% of cases, the chromatin was not 
coarse. Conversely, in the higher grades a higher percentage (63% and 45% of 
Grades 3 and 4 respectively) of cells showed coarse clumping . of the nuclear 
chromatin which is a cytological feature of neoplasia. The majority of the grade 
3 EGA's were histologically confirmed CIN3 lesions and the coarse chromatin 
distribution within nuclei is consistent with this. The observation of the 
architectural features in addition to the cytological features is important in 
distinguishing squamous CIN3 from severe EGA. 
In some cases however, normal or slightly atypical endocervical cells persisted at 
the edge of sheets of dysplastic cells, leading the screener to assume the sheets 
were glandular in origin. 
Many of the histologically confirmed cases of AIS in fact had hyperchromatic 
dense nuclear chromatin rather than coarse clumping and this feature has been 
observed by other authors (Nguyen & jennot 1984, Lee et al 1991). 
The types of nucleoli as demonstrated in Figure 9 are of little value in 
separating grade of EGA. Micronucleoli are generally present in any reactive 
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endocervical cell and when inflammation and repair are present macronucleoli are 
frequently seen, so this feature is not useful in separating neoplastic from benign 
conditions. (Ill 14, 15) 
Mitosis and apoptosis was infrequently demonstrated (Figure XV) and were only 
present in Grade 3 and 4 EGA's. Jaworski (1990) places significant value on their 
presence in histological sections, particularly when architectural features 
suggestive of AIS are seen. Other authors (Lee et al 1991, Ayer et al 1987) 
.· 
encountered mitoses and apoptoses less frequently and in the context of 
cytological evaluation they appear to be less useful criteria. 
5.3.3 BACKGROUND FEATURES OF SMEARS 
Figure 10 demonstrates the similar relative frequencies between all grades of 
EGA indicating that background features are not helpful in the diagnosis of 
precursor lesions of malignancy. This is confirmed by other authors (Jaworski 
1990, Lee et al 1991). 
5.3.4 MISCELLANEOUS FEATURES OF SMEARS . -:'"'· 
5.3.4.1 Exfoliated endometrial cells· 
Although no separate category had been supplied on the data collection form for 
the presence of endometrial cells on the cervical smears, it was noted on 
rescreening that when exfoliated endometrial cells were present on the smears a 
high proportion of these were interpreted as " atypical glandular cells of 
endocervical origin". Although endometrial cells were present in only 20 cases of 
the total sample, 12 (60%) were interpreted as EGA. Classically endometrial cells 
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tend to "ball-up" into three dimensional clusters and the rather hyperchromatic 
degenerate nuclei can lead to misinterpretation. (Ill 32). In two of the 20 cases 
flat sheets of endometrial cells were directly exfoliated from the lower segment 
of the uterus by an endocervical brush in a post conised cervix. (Ill 33). 
Endometrial cells under these circumstances tend to be more closely packed, and 
hypercellular. The presence of both glands and stroma aids in interpretation of 
these cases. 
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6. CONCLUSIONS AND RECOMMENDATIONS 
6.1 CONCLUSIONS 
This analysis of the grading system of endocervical glandular atypias at present 
in use at Groote Schuur Hospital Cytology Laboratory, has shown: 
6.1.1 GRADE 1. 
The diagnosis of mild endocervical atypias (Grade 1) has been inappropriately 
applied in the majority of cases, due to the following reasons: 
a) The majority (7 4.8%) of cases regressed and no cases deteriorated 
over the five year follow-up period. In those cases which 
regressed, it was found that anisonucleosis was the most frequently 
occurring feature. In addition, many of the smears were 
inflammatory and showed regenerative changes. These features 
should not have led to the · diagnosis of "mild atypia" but a 
descriptive diagnosis should rather have been given. 
b) Grade 1 cases which persisted were frequently associated with 
squamous epithelial abnormalities, in particular human papilloma 
virus infection. These changes should be reported as HPV alone. 
The diagnosis of mild cervical atypia should only be used when no causative 
process is evident. 
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6.1.2 GRADE 2: 
The data in this group also shows that the diagnosis of "atypia" was inappropriate 
in many cases. Forty percent of cases regressed in this heterogeneous group. 
Persistence of abnormalities again appears to be related to squamous atypias, in 
particular CIN. Histological correlation, where available, confirms this impression. 
Many of the so-called moderately atypical endocervical cells appear to be 
immature metaplastic cells showing dysplastic changes, and should be interpreted 
and managed as such. Where there was no squamous abnormality, apart' from 
regeneration, the atypia regressed in the majority of cases. 
6.1.3 GRADE 3: 
Similar features are noted in this severe endocervical atypia group. Although 2 of 
the 20 cases which received histological. correlation were endocervical glandular 
neoplasms, the majority were squamous CIN3 lesions extending into crypts. 
This difficulty in interpretation has been observed by other authors (Staymates 
1982, Coleman & Evans 1988). Abnormal architectural features, and particularly 
accumulative architectural features, are necessary for the reliable cytological 
diagnosis of AIS and similarly EGD. Without these architectural features, which 
have been well described in the comprehensive descriptions available, the 
diagnosis should not be suggested. 
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6.1.4 GRADE 4: 
This most severe group of cases where the diagnosis of AIS was suggested in the 
original cytology report is small, but conforms to the pattern described in the 
literature. Endocervical hyperplasia, in particular microglandular hyperplasia, 
presents a problem in cytological interpretation. Further research is required in 
this area. 
The . Bethesda System emphasises the need to classify cervical Pap-smear 
abnormalities in terms of causation, if possible stipulating whether a benign 
reactive process is favoured rather than a neoplastic or pre-neoplastic process. 
There is also a need to determine clearly if possible which cells are showing the 
abnormality. The results of this study confirm these recommendations. 
6.2 RECOMMENDATIONS 
1. The diagnosis of mild atypia should not be used indiscriminately. 
2. Cervical Pap-smear abnormalities should, if possible, be classified in terms 
of causation, stipulating whether a benign reactive process or a neoplastic 
process is favoured. This requires the diagnostic cytologist to have a 
good working knowledge of normal endocervical cells under a wide range of 
conditions. 
3. Only when the glandular abnormalities correspond to those described as 
relating to AIS, should this diagnosis be made. It should be remembered 
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that accumulative features are of more diagnostic significance than single 
features. 
4. Where squamous epithelial abnormalities predominate, the diagnosis of CIN 
etc. should be made rather than endocervical atypia. However, if the 
described glandular abnormalities are in addition present, AIS/EGD 
coexistant with CIN should be considered. 
5. The Bethesda system provides a diagnostic category termed atypical 
glandular cells of undetermined significance and wherever none of the 
above can be applied, this diagnosis should be considered. An invariably 
accurate prediction is not always possible on cytology, particularly when 
smears are obscured by inflammatory exudate or blood. Repeat smears 
and/or colposcopy may be necessary for further evaluation. 
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